PLN 2.37
(-1.25%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -7.88 Million PLN | -922.61% |
2022 | -771.54 Thousand PLN | 92.78% |
2021 | -10.68 Million PLN | -101.19% |
2020 | -5.3 Million PLN | -240.01% |
2019 | -1.56 Million PLN | 33.39% |
2018 | -2.34 Million PLN | -16.45% |
2017 | -2.01 Million PLN | -156.11% |
2016 | -786.14 Thousand PLN | -9.77% |
2015 | -716.17 Thousand PLN | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -1.35 Million PLN | -5.21% |
2024 Q1 | -1.28 Million PLN | 57.38% |
2023 Q3 | -1.45 Million PLN | 8.49% |
2023 Q1 | -1.84 Million PLN | -160.37% |
2023 Q2 | -1.59 Million PLN | 13.73% |
2023 FY | -7.88 Million PLN | -922.61% |
2023 Q4 | -3.01 Million PLN | -107.55% |
2022 Q2 | -874.42 Thousand PLN | 74.11% |
2022 FY | -771.54 Thousand PLN | 92.78% |
2022 Q4 | 3.05 Million PLN | 329.82% |
2022 Q3 | -1.32 Million PLN | -51.91% |
2022 Q1 | -3.37 Million PLN | 50.36% |
2021 Q1 | -1.07 Million PLN | 74.41% |
2021 Q2 | -1.49 Million PLN | -38.84% |
2021 FY | -10.68 Million PLN | -101.19% |
2021 Q3 | -1.15 Million PLN | 23.28% |
2021 Q4 | -6.8 Million PLN | -491.61% |
2020 Q2 | -400.51 Thousand PLN | 7.1% |
2020 Q1 | -431.14 Thousand PLN | 48.47% |
2020 FY | -5.3 Million PLN | -240.01% |
2020 Q4 | -4.21 Million PLN | -2961.93% |
2020 Q3 | -137.81 Thousand PLN | 65.59% |
2019 Q2 | -383.92 Thousand PLN | -189.61% |
2019 Q1 | -132.56 Thousand PLN | 10.72% |
2019 FY | -1.56 Million PLN | 33.39% |
2019 Q3 | -183.01 Thousand PLN | 52.33% |
2019 Q4 | -836.61 Thousand PLN | -357.14% |
2018 Q2 | -830.8 Thousand PLN | -0.95% |
2018 Q3 | -542.34 Thousand PLN | 34.72% |
2018 FY | -2.34 Million PLN | -16.45% |
2018 Q4 | -148.48 Thousand PLN | 72.62% |
2018 Q1 | -822.97 Thousand PLN | -8.34% |
2017 Q2 | -372.56 Thousand PLN | 20.59% |
2017 FY | -2.01 Million PLN | -156.11% |
2017 Q3 | -412.1 Thousand PLN | -10.61% |
2017 Q1 | -469.15 Thousand PLN | 0.0% |
2017 Q4 | -759.6 Thousand PLN | -84.32% |
2016 FY | -786.14 Thousand PLN | -9.77% |
2015 FY | -716.17 Thousand PLN | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Bioceltix S.A. | -13.68 Million PLN | 42.358% |
BIOTON S.A. | 2.27 Million PLN | 446.805% |
Captor Therapeutics Spolka Akcyjna | -70.58 Million PLN | 88.822% |
Mabion S.A. | 41.26 Million PLN | 119.118% |
Molecure S.A. | -18.3 Million PLN | 56.906% |
Pharmena S.A. | 28.94 Million PLN | 127.262% |
Poltreg S.A. | -13.55 Million PLN | 41.777% |
Pure Biologics Spólka Akcyjna | -35.69 Million PLN | 77.896% |
Ryvu Therapeutics S.A. | -92.11 Million PLN | 91.435% |
Synthaverse S.A. | 4.75 Million PLN | 265.822% |
Urteste S.A. | -5.58 Million PLN | -41.243% |